CompoAtlas

Yi Huang Tang Capsule

Natural health product licensed in Canada

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Phellodendron chinense

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 300 mg

30 mgNot calculated
Euryale ferox

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 1,500 mg

150 mgNot calculated
Ginkgo biloba

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 600 mg

60 mgNot calculated
Plantago asiatica

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 150 mg

15 mgNot calculated
Dioscorea oppositifolia

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 1,500 mg

150 mgNot calculated

Non-medicinal ingredients

Hypromellose, Stéarate de magnésium, Cellulose, Dextrine

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years2 Capsule2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Combination of Traditional Chinese Medicine Ingredients.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Other names
Cyctek Yi Huang Tang Capsule
Licence holder
CycTek Inc.
NPN or DIN-HM
80145526
Status
Active licence
Licence date
24 November 2025
Revision date
Not provided
Form
Capsule, dur
Route of administration
Orale
Application type
Officinale

Source

Official Health Canada record, licence 80145526

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Ginkgo biloba
    Read the warning, when it applies and the studies cited

    GINKGO - GINKGO BILOBA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).

    Sources cited by Health Canada (3)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
    • WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
    • OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Contraindications

    Do not use if you are having a surgery (Gardner and McGuffin 2013).

    Sources cited by Health Canada (1)
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).

    Sources cited by Health Canada (3)
    • Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Systematic review
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Health Canada monograph dated 25 July 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Yi Huang Tang Capsule”, https://compoatlas.com/en/supplements/canada/80145526-yi-huang-tang-capsule, updated 24 November 2025.

Enter to analyse, Shift+Enter for a new line